These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26671829)

  • 1. Study of antibody repertoires to the CD4 binding site of gp120 of a Chinese HIV-1-infected elite neutralizer, using 454 sequencing and single-cell sorting.
    Li D; Wang Z; Ren L; Zhang J; Feng G; Hong K; Hao Y; Qi Z; Liang H; Shao Y
    Arch Virol; 2016 Apr; 161(4):789-99. PubMed ID: 26671829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
    Sun Z; Li J; Hu X; Shao Y; Zhang MY
    Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-Pan-neutralizing, Plasma Deconvoluted Antibody N49P6 Mimics Host Receptor CD4 in Its Quaternary Interactions with the HIV-1 Envelope Trimer.
    Tolbert WD; Nguyen DN; Tehrani ZR; Sajadi MM; Pazgier M
    mBio; 2021 Aug; 12(4):e0127421. PubMed ID: 34281393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site.
    Wu X; Wang C; O'Dell S; Li Y; Keele BF; Yang Z; Imamichi H; Doria-Rose N; Hoxie JA; Connors M; Shaw GM; Wyatt RT; Mascola JR
    J Virol; 2012 May; 86(10):5844-56. PubMed ID: 22419808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.
    Duan H; Chen X; Boyington JC; Cheng C; Zhang Y; Jafari AJ; Stephens T; Tsybovsky Y; Kalyuzhniy O; Zhao P; Menis S; Nason MC; Normandin E; Mukhamedova M; DeKosky BJ; Wells L; Schief WR; Tian M; Alt FW; Kwong PD; Mascola JR
    Immunity; 2018 Aug; 49(2):301-311.e5. PubMed ID: 30076101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site.
    Li L; Wang XH; Williams C; Volsky B; Steczko O; Seaman MS; Luthra K; Nyambi P; Nadas A; Giudicelli V; Lefranc MP; Zolla-Pazner S; Gorny MK
    Mol Immunol; 2015 Aug; 66(2):364-74. PubMed ID: 25965315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.
    Wu X; Zhou T; Zhu J; Zhang B; Georgiev I; Wang C; Chen X; Longo NS; Louder M; McKee K; O'Dell S; Perfetto S; Schmidt SD; Shi W; Wu L; Yang Y; Yang ZY; Yang Z; Zhang Z; Bonsignori M; Crump JA; Kapiga SH; Sam NE; Haynes BF; Simek M; Burton DR; Koff WC; Doria-Rose NA; Connors M; ; Mullikin JC; Nabel GJ; Roederer M; Shapiro L; Kwong PD; Mascola JR
    Science; 2011 Sep; 333(6049):1593-602. PubMed ID: 21835983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a VRC01-like antibody lineage with immature V
    Hu Y; Li D; Yuan Z; Feng Y; Ren L; Hao Y; Wang S; Hu X; Liu Y; Hong K; Shao Y; Wang Z
    Mol Immunol; 2023 Feb; 154():11-23. PubMed ID: 36577292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An HIV-1 envelope immunogen with W427S mutation in CD4 binding site induced more T follicular helper memory cells and reduced non-specific antibody responses.
    Yu HT; Tian D; Wang JY; Guo CX; Li Y; Wang X; Li D; Zhang FM; Zhuang M; Ling H
    PLoS One; 2014; 9(12):e115047. PubMed ID: 25546013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual.
    Khan L; Makhdoomi MA; Kumar S; Nair A; Andrabi R; Clark BE; Auyeung K; Bhattacharya J; Vajpayee M; Wig N; Pantophlet R; Luthra K
    PLoS One; 2015; 10(5):e0125575. PubMed ID: 25962059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
    Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
    J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.
    Wu X; Yang ZY; Li Y; Hogerkorp CM; Schief WR; Seaman MS; Zhou T; Schmidt SD; Wu L; Xu L; Longo NS; McKee K; O'Dell S; Louder MK; Wycuff DL; Feng Y; Nason M; Doria-Rose N; Connors M; Kwong PD; Roederer M; Wyatt RT; Nabel GJ; Mascola JR
    Science; 2010 Aug; 329(5993):856-61. PubMed ID: 20616233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.
    Bonsignori M; Zhou T; Sheng Z; Chen L; Gao F; Joyce MG; Ozorowski G; Chuang GY; Schramm CA; Wiehe K; Alam SM; Bradley T; Gladden MA; Hwang KK; Iyengar S; Kumar A; Lu X; Luo K; Mangiapani MC; Parks RJ; Song H; Acharya P; Bailer RT; Cao A; Druz A; Georgiev IS; Kwon YD; Louder MK; Zhang B; Zheng A; Hill BJ; Kong R; Soto C; ; Mullikin JC; Douek DC; Montefiori DC; Moody MA; Shaw GM; Hahn BH; Kelsoe G; Hraber PT; Korber BT; Boyd SD; Fire AZ; Kepler TB; Shapiro L; Ward AB; Mascola JR; Liao HX; Kwong PD; Haynes BF
    Cell; 2016 Apr; 165(2):449-63. PubMed ID: 26949186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel broadly HIV-1-neutralizing antibody from a CRF01_AE-infected Chinese donor.
    Ju B; Li D; Ren L; Hou J; Hao Y; Liang H; Wang S; Zhu J; Wei M; Shao Y
    Emerg Microbes Infect; 2018 Nov; 7(1):174. PubMed ID: 30382080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N463 Glycosylation Site on V5 Loop of a Mutant gp120 Regulates the Sensitivity of HIV-1 to Neutralizing Monoclonal Antibodies VRC01/03.
    Wang W; Zirkle B; Nie J; Ma J; Gao K; Chen XS; Huang W; Kong W; Wang Y
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):270-7. PubMed ID: 25751231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.
    Li Y; O'Dell S; Walker LM; Wu X; Guenaga J; Feng Y; Schmidt SD; McKee K; Louder MK; Ledgerwood JE; Graham BS; Haynes BF; Burton DR; Wyatt RT; Mascola JR
    J Virol; 2011 Sep; 85(17):8954-67. PubMed ID: 21715490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization.
    Navis M; Tran K; Bale S; Phad GE; Guenaga J; Wilson R; Soldemo M; McKee K; Sundling C; Mascola J; Li Y; Wyatt RT; Karlsson Hedestam GB
    PLoS Pathog; 2014 Aug; 10(8):e1004337. PubMed ID: 25166308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection.
    Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F
    J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for germline antibody recognition of HIV-1 immunogens.
    Scharf L; West AP; Sievers SA; Chen C; Jiang S; Gao H; Gray MD; McGuire AT; Scheid JF; Nussenzweig MC; Stamatatos L; Bjorkman PJ
    Elife; 2016 Mar; 5():. PubMed ID: 26997349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of CD4 binding site antibodies during HIV-1 infection.
    Lynch RM; Tran L; Louder MK; Schmidt SD; Cohen M; ; Dersimonian R; Euler Z; Gray ES; Abdool Karim S; Kirchherr J; Montefiori DC; Sibeko S; Soderberg K; Tomaras G; Yang ZY; Nabel GJ; Schuitemaker H; Morris L; Haynes BF; Mascola JR
    J Virol; 2012 Jul; 86(14):7588-95. PubMed ID: 22573869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.